[1]
Noviyani, R., Indrayathi, P.A., Budiana, I.N.G., Suwiyoga, K. and Putri, S. 2017. DIFFERENCE OF TUMOR MASS IN STADIUM IIB-IIIB SQUAMOUS CELL CERVICAL CANCER PATIENTS WHO UNDERWENT PACLITAXEL CISPLATIN AND PACLITAXEL CARBOPLATIN CHEMOTHERAPY AT SANGLAH HOSPITAL DENPASAR. International Journal of Pharmacy and Pharmaceutical Sciences. 9, 10 (Nov. 2017), 139–143. DOI:https://doi.org/10.22159/ijpps.2017v9i11.21375.